Lack of sustained hemodynamic effects of the beta 2-adrenoceptor agonist dopexamine in end-stage congestive heart failure.
Böhm
M
M
Medizinische Klinik I der Universität München, Federal Republic of Germany.
Reuschel-Janetschek
E
E
Erdmann
E
E
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use*; D000328:Adult; D004298:Dopamine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy*; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D008875:Middle Aged
D000318:Adrenergic beta-Agonists; C046318:dopexamine; D004298:Dopamine